Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
The effect of exogenous sex steroids on the vaginal microbiota: A systematic review.
Ratten LK, Plummer EL, Bradshaw CS, Fairley CK, Murray GL, Garland SM, Bateson D, Tachedjian G, Masson L, Vodstrcil LA
(2021), FRONT CELL INFECT MI, 11, 732423
Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
Plummer EL, Bradshaw CS, Doyle M, Fairley CK, Murray GL, Bateson D, Masson L, Slifirski J, Tachedjian G, Vodstrcil LA
(2021), PLoS One, 16(2), e0246953
The phases of hepatitis C elimination: achieving WHO elimination targets.
Pedrana A, Munari S, Stoové M, Doyle J, Hellard M
(2021), LANCET GASTROENTEROL, 6(1), 6-Aug
Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics.
Papaluca T, Roberts SK, Strasser SI, Stuart KA, Farrell G, MacQuillan G, Dore GJ, Wade AJ, George J, Hazeldine S, O'Beirne J, Wigg A, Fisher L, McGarity B, Sawhney R, Sinclair M, Thomas J, Valiozis I, Weltman M, Wilson M, Woodward A, Ahlenstiel G, Haque M
(2021), Clin Infect Dis, 73(9), e3295
DOI: 10.1093/cid/ciaa1318
A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign.
Palmer AY, Chan K, Gold J, Layton C, Elsum I, Hellard M, Stoove M, Doyle JS, Pedrana A, Scott N; EC Partnership
(2021), J VIRAL HEPATITIS, 28(11), 1624-34
DOI: 10.1111/jvh.13596
Barriers and facilitators to pre-exposure prophylaxis among African migrants in high income countries: a systematic review
Mwaturura C, Traeger M, Lemoh C, Stoove M, Price B, Coelho A, Mikola M, Ryan KE, Wright E
(2021), Sex Health, 18(2), 130-9
DOI: 10.1071/sh20175
A new method for estimating the incidence of infectious diseases.
McManus H, Callander D, Asselin J, McMahon J, Hoy JF, Templeton DJ, Fairley CK, Donovan B, Pedrana AE, Keen P, Wilson DP, Elliott J, Kaldor J, Liaw ST, Petoumenos K, Holt M, Hellard ME, Grulich AE, Carr A, Stoové MA, Guy RJ
(2021), Am J Epidemiol, 190(7), 1386–95
DOI: 10.1093/aje/kwab014
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial.
McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Sinclair B, Reid D, Baker AL, Manning V, Pas NT, Thomas T, Bathish R, Raftery DK, Wrobel A, Saunders L, Arunogiri S, Cordaro F, Hill H, Hall S, Clare PJ, Mohebbi M, B
(2021), EClinicalMedicine, 38, 101005
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers.
McKenzie CI, Varese N, Aui PM, Wines BD, Hogarth PM, Thien F, Hew M, Rolland JM, O'Hehir RE, van Zelm MC
(2021), Allergy, 76(10), 3028-40
DOI: 10.1111/all.14832
Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in Australia.
Lubel JS, Roberts SK, Howell J, Ward J, Shackel NA
(2021), Intern Med J, 51(2), 181-8
DOI: 10.1111/imj.15184
A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination.
Lemke MM, McLean MR, Lee CY, Lopez E, Bozich ER, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kratochvil S, Wines BD, Hogarth PM, Kent SJ, Chung AW, Arnold KB
(2021), Cell Reports Medicine, 2(9), 100386
Implications of HIV self-testing for other sexually transmissible infection testing and broader sexual health needs: a mixed methods study of gay and bisexual men in Australia.
Leitinger D, Ryan K, Wilkinson AL, Pedrana A, Hellard M, Stoové M
(2021), Sex Transm Dis, 48(6), 417-23
Decay of Fc-dependent antibody functions after mild to moderate COVID-19.
Lee WS, Selva KJ, Davis SK, Wines BD, Reynaldi A, Esterbauer R, Kelly HG, Haycroft ER, Tan HX, Juno JA, Wheatley AK, Hogarth PM, Cromer D, Davenport MP, Chung AW, Kent SJ
(2021), Cell Reports Medicine, 2(6), 100296
Early outpatient treatment of SARS-CoV-2 (COVID-19): A comment.
Korman TM, McMahon JH
(2021), AM J MED, 134(3), e220-e221
Effect of disease modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years.
Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Jokubaitis V, van der Walt A, Grand'Maison F, Sola P, Ferraro D, Shaygannejad V, Alroughani R, Hupp
(2021), Neurology, 96(5), e783-e797
Multicentre stepped-wedge cluster randomised controlled trial of an antimicrobial stewardship programme in residential aged care: protocol for the START trial.
Jokanovic N, Haines T, Cheng AC, Holt KE, Hilmer SN, Jeon YH, Stewardson AJ, Stuart RL, Spelman T, Peel TN, Peleg AY; START Trial Group
(2021), BMJ Open, 11(3), e046142
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.
Hensen L, Nguyen THO, Rowntree LC, Damelang T, Koutsakos M, Aban M, Hurt A, Harland KL, Auladell M, van de Sandt CE, Everitt A, Blacker C, Oyong DA, Loughland JR, Webb JR, Wines BD, Hogarth PM, Flanagan KL, Plebanski M, Wheatley A, Chung AW, Kent SJ, Mill
(2021), P NATL ACAD SCI USA, 118(41), e2109388118
Affordable treatment and political commitment are crucial to eliminate hepatitis C globally.
Hellard M, Pedrana A, Draper B
(2021), LANCET GASTROENTEROL, 6(6), 414-6
Effect of Rosuvastatin therapy on biomarkers of inflammation and immune activation in people with Human Immunodeficiency Virus at intermediate cardiovascular risk.
Hearps AC, Angelovich TA, Trevillyan JM, Wong ME, Calmy A, Hoy JF, Jaworowski A
(2021), J Infect Dis, 224(4), 667-72
Letter to the Editor: Recommendations for implementing hepatitis C virus care in homeless shelters: The stakeholder perspective.
Harney B, McColl R, Pedrana A, Morrison E, Doyle J, Hellard M, Higgs P
(2021), Hepatol Commun, 5(1), 146-7
DOI: 10.1002/hep4.1616